15 Mixed cryoglobulinemia and other extrahepatic manifestations of hepatitis C virus infection

Biomedical Research Reports

Volumn 2, Issue C, 2000, Pages

  Agnello, Vincent ^a,b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957075632     PISSN: 18745326     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5326(00)80019-8     Document Type: Article

References (86)

1. Wintrobe M.M., and Buell M.V. Hyperproteinemia associated with multiple myeloma, with report of a case in which extraordinary hyperproteinemia was associated with thrombosis of retinal veins and symptoms suggesting Reynaud's disease. Bull Johns Hopkins Hosp 52 (1933) 156-165
2. Lerner A.B., and Watson C.J. Studies of cryoglobulins; Unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 214 (1947) 410-415
3. Lospalluto J., Dorward B., Miller Jr. W., and Ziff M. Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin. Am J Med 32 (1962) 142-147
4. Meltzer M., Franklin E.C., Elias K., McCluskey R.T., and Cooper N. Cryoglobulinemia: a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40 (1966) 837-856
5. Monti G., Galli M., Invernizzi F., et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinemias. Q J Med 88 (1995) 115-126
6. Pascual M., Perrin L., Giostra E., and Schifferli J.A. Hepatitis C virus in patients with cryoglobulinemia type II (letter). J Infect Dis 162 (1990) 569-570
7. Agnello V., and Romain P.L. Mixed cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am 22 (1996) 1-21
8. Agnello V., Chung R.T., and Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 (1992) 1490-1495
9. Johnson R.J., Gretch D.R., Yamabe H., et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328 (1993) 465-470
10. Levey J.M., Bjornsson B., Banner B., et al. Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature. Medicine 73 (1994) 53-67
11. Agnello V., Joslin F.G., and Kunkel H.G. Cross idiotypic specificity among monoclonal IgM anti-globulins. Scand J Immunol 1 (1972) 283
12. Kunkel H.G., Agnello V., Joslin F.G., Winchester R.J., and Capra J.D. Cross-idiotypic specificity among monoclonal IgM proteins with anti-g-globulin activity. J Exp Med 137 (1973) 331-342
13. Bonomo L., Casato M., Afeltra A., and Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 83 (1987) 726-730
14. Casato M., Agnello V., Pacillo L.P., et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90 (1997) 3865-3873
15. Brouet J.C., Clauvel J.P., Danon F., Klein M., and Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 57 (1974) 775-788
16. Agnello V. Mixed cryoglobulinemia after hepatitis C virus: more and less ambiguity. Ann Rheum Dis 57 (1998) 701-702
17. Musset L., Diemert M.C., Taibi F., et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 38 (1992) 798-802
18. Gigli I. Complement avtivation in patients with mixed cryoglobulinemia. In: Ponticelli C., Minetti L., and D'Amico G. (Eds). Antiglobulins, cryoglobulins, and glomerulonephritis (1986), Martinus Nijhoff, Dordrecht, The Netherlands 135-146
19. Circolo A., Barnes J.L., and Agnello V. Inhibition of complement activation by anti-cross-idiotype antibodies. FASEB J 2 (1988) A1647
20. Maggiore Q., Bartolomeo F., L'Abbate A., et al. Glomerular localization of circulating antiglobulin activity in essential mixed cryoglobulinemia with glomerulonephritis. Kidney Int 21 (1982) 387-394
21. Hanauer L.B., and Christian C.L. Studies of cryoproteins in systemic lupus erythematosus. J Clin Invest 46 (1967) 400-408
22. Agnello V., Zhang Q.X., Abel G., and Knight G.B. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin Exp Rheum 13 Suppl 13 (1995) S101-S104
23. Agnello V., and Barnes J.L. Human rheumatoid factor cross-idiotypes I: WA and BLA are heat-labile conformational antigens requiring both heavy and light chains. J Exp Med 164 (1986) 1809-1814
24. Gorevic P.D., and Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 28 (1991) 79-94
25. Agnello V., Arbetter A., Ibanez de Kasep G., Powell R., Tan E.M., and Joslin F. Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have distinct cross-idiotype. J Exp Med 151 (1980) 1514-1527
26. Cacoub P., Fabiani F.L., Musset L., et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96 (1994) 124-132
27. Lunel F., Musset L., Cacoub P., et al. Cryoglobulinemia in chronic liver diseases: the role of hepatitis C virus and liver damage. Gastroenterology 106 (1994) 1291-1300
28. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 19 (1997) 111-129
29. Shakil A.O., and Di Bisceglie A.M. Vasculitis and cryoglobulinemia related to hepatitis C. N Engl J Med 331 (1994) 1624
30. D'Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 54 (1998) 650-671
31. Invernizzi F., Galli M., Serino G., et al. Secondary and essential cryoglobulinemias. Frequency, nosological classification and long-term follow-up. Acta Haematol 70 (1983) 73-82
32. Tarantino A., Campise M., Banfi G., et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47 (1995) 618-623
33. Johnson R.J., Wilson R., Yambe H., et al. Renal manifestations of hepatitis C virus infection. Kidney Int 46 (1994) 1255-1263
34. Ferri C., LaCivita L., Cirafis C., et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 19 (1992) 889-895
35. Gorevic P.D., Kassab H.J., Levo Y., et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69 (1980) 287-308
36. Cattaneo R., Fenini M.G., and Facchetti F. The cryoglobulinemic vasculitis. Ric Clin Lab 16 (1986) 327-333
37. Sansonno D., Cornacchiulo V., Iacobelli A.R., Di Stefano R., Lospalluti M., and Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 21 (1995) 305-312
38. Agnello V., and Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II mixed cryoglobulinemia using in situ hybridization. Arthritis Rheum 40 (1997) 2007-2015
39. D'Amico G., Colasanti G., Ferrario R., and Sinico R.A. Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35 (1989) 1004-1014
40. Sinico R.A., Winearls C.G., Sabadini E., Fornasieri A., Castiglione A., and D'Amico G. Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis. Kidney Int 34 (1988) 109-116
41. Cordonnier D., Martin H., Groslambert P., Micouin C., Chenais F., and Stoebner P. Mixed IgG-IgM cryoglobulinemia with glomerulonephritis. Immunochemical fluorescent and ultrastructural study of kidney and in vitro cryoprecipitate. Am J Med 59 (1975) 867-872
42. Stoebner P., Renversez J.C., Groulade J., Vialtel P., and Cordonnier D. Ultrastructural study of human IgG IgM crystalcryoglobulins. Am J Clin Pathol 71 (1978) 404-410
43. Reininger L., Berney T., Shibata T., Spertini F., Merino R., and Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc Natl Acad Sci U S A 87 (1990) 10038-10042
44. Fornasieri A., Li M., Armelloni S., et al. Glomerulonephritis induced by human IgMκ-IgG cryoglobulins in mice. Lab Invest 69 (1993) 531-540
45. Fornasieri A., Armelloni S., Bernasconi P., et al. High binding of immunoglobulin Mκ rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis. Am J Kidney Dis 27 (1996) 476-483
46. Yamabe H., Inuma H., Osawa H., et al. Glomerular deposition of hepatitis C virus in membranoproliferative glomerulonephritis. Nephron 72 (1996) 741
47. Sansonno D., Gesualdo L., Manno C., Schena F.P., and Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membrano-proliferative glomerulonephritis. Hepatology 25 (1997) 1237-1244
48. Agnello V. Immune complexes in hepatitis C (letter). Hepatology 26 (1997) 1687-1688
49. Scheuer P.J., and Krawczynski Dhillon A.P. Histopathology and detection of hepatitis C virus in liver. Springer Semin Immunopathol 19 (1997) 27-45
50. Monteverde A., Ballare M., and Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 19 (1997) 99-110
51. Agnello V., Abel G., Zhang Q.X., Knight G.B., and Muchmore E. Detection of widespread hepatocyte infection in chronic hepatitis C. Hepatology 28 (1998) 573-584
52. Monteverde A., Sabattini E., Poggi S., et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma 2 (1995) 119-124
53. Galli M., Zehender G., Monti G., et al. Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C. Infect Dis 171 (1995) 672-675
54. Lanford R.E., Chavez D., Chisari F.V., and Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. Virology 69 (1995) 8079-8083
55. Muratori L., Gibellini D., Lenzi M., et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 88 (1996) 2768-2774
56. Laskus T., Radkowski M., Wang L., Sook J.L., Vargas H., and Rakela J. Hepatitis C virus quasi species in patients infected with HIV-1. Correlation with extrahepatic viral replication. Virology 248 (1998) 164-171
57. Monteverde A., Rivano M.T., Allegra G.C., et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 79 (1988) 20-25
58. Mussini C., Mascia M.T., Zanni G., Curci G., Bonacorsi G., and Artusi T. A cytomorphological and immunohistochemical study of bone marrow in the diagnosis of essential mixed type II cryoglobulinemia. Haematologica 76 (1991) 389-391
59. Pozzato G., Mazzaro C., Crovatto M., et al. Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. Blood 84 (1994) 3047-3053
60. Ballare M., De Vita S., Bertoncelli M.C., Pivetta B., Biocchi M., and Pileri S. Clinical, pathological and molecular differences between the bone marrow lymphoproliferation and the overt B-cell lymphomas in patients with the type II mixed cryoglobulinemia and the HCV infection. Abstr. 4th Intern Meet HCV Relat Virus. Kyoto, Jpn (1997) 222
61. Casato M., Lagana B., Antonelli G., Dianzani F., and Bonomo L. Long-term results of therapy with interferon-α for type II essential mixed cryoglobulinemia. Blood 78 (1991) 3142-3147
62. Ferri C., Marzo E., and Longombardo G. Interferon alfa and mixed cryoglobulinemia patients: A randomized crossover-controlled trial. Blood 81 (1993) 1132-1136
63. Misiani R., Bellavita P., Fenili D., et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117 (1992) 573-577
64. Dammacco F., Sansonno D., Han J.H., et al. Natural interferon-α versus its combination with 6-methyl-prednisolone in therapy of type II mixed cryoglobulinemia: A long term, randomized, controlled study. Blood 84 (1994) 3336-3343
65. Pawlotsky J.M., Roudot-Thoraval F., Simmonds P., et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122 (1995) 169-173
66. Ferri C., Monti M., LaCivita L., Longombardo G., Greco F., Pasero G., Gentilini P., Bombardieri S., and Zignego A.L. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82 (1993) 3701-3704
67. Sansonno D., DeVita S., Iacobelli A.R., et al. Clonal analysis of intra hepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. Immunology 160 (1998) 3594-3601
68. Ray R.B., Lagging L.M., Meyer K., et al. Transcriptional regulation of cellular and viral promotors by the hepatitis C virus core protein. Virus Res 37 (1995) 209-220
69. Ray R.B., Lagging L.M., Meyer K., et al. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblast to tumorigenic phenotype. J Virol 70 (1996) 4438-4443
70. De Vita S., Sasonno D., Dolcetti R., et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 86 (1995) 1887-1892
71. Ascoli V., Lo Coco F., Artini M., et al. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 109 (1998) 600-609
72. Strassburg C.P., Obermayer-Straub P., and Manns M.P. Autoimmunity in hepatitis C and D virus infection. J Viral Hepatitis 3 (1996) 49-59
73. Haddad J., Deny P., Gotheil C.M., et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339 (1992) 321-323
74. Pirisi M., Scott C., Fabris C., et al. Mild sialadenitis: a common finding inpatients with hepatitis C virus infection. Scand J Gastroenterol 29 (1994) 940-942
75. King P.D., McMurray R.W., and Becherer P.R. Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 89 (1994) 1047-1050
76. Kioke K., Moriya K., Ishibashi K., et al. Sialadenitis histologic resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A 94 (1997) 233-236
77. Stehman-Breen C., Wilson R., and Johnson R.J. Is there a hepatitis C-associated membranoproliferative glomerulonephritis?. Am J Kidney Dis 30 (1997) 189-190
78. Mishiro S., Hoshi Y., Takeda K., et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 336 (1990) 1400-1403
79. Clifford B.D., Donahue D., Smith L., et al. High prevalence of serologic markers of autoimmunity inpatients with chronic hepatitis C. Hepatology 21 (1995) 613-619
80. Sachithanandan S., and Fielding J.F. Autoimmune disease is not a feature of hepatitis C infection in Ireland. J Clin Gastroenterol 25 (1997) 522-524
81. Tran A., Quaranta J.F., Benzaken S., et al. High prevalence of thyroid autoantibodies in a prospective series of patients of patients with chronic hepatitis C before interferon therapy. Hepatology 18 (1993) 253-257
82. Boadas J., Rodriguez-Espinosa J., and Enriquez J. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C infection. Hepatology 22 (1995) 611-615
83. Marazuela M., García-Buey L., González-Fernández B., García-Monzón C., Arranz A., Borque M.J., and Moreno-Otero R. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy. Clin Endocrinol 44 (1996) 635-642
84. Watanabe U., Hashimoto E., Hisamitsu T., et al. The risk factor for development of thyroid disease during interferon α therapy for chronic hepatitis C. Am J Gastroenterol 89 (1994) 399-403
85. Cacoub P., Musset L., Amoura Z., et al. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group. J Rheumatol 24 (1997) 2139-2144
86. Mecchia M., Casato M., Rosalba T., et al. Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG-3 protein. J Immunol 157 (1996) 3727-3736